Article Cited by others

RESEARCH PAPER

Effect of rolipram, a phosphodiesterase enzyme type-4 inhibitor, on γ:-amino butyric acid content of the frontal cortex in mice exposed to chronic mild stress

Shalaby Amany Mohamed, Kamal Sahar Mohamed

Year : 2012| Volume: 3| Issue : 2 | Page no: 132-137

   This article has been cited by
 
1 Etazolate abrogates the lipopolysaccharide (LPS)-induced downregulation of the cAMP/pCREB/BDNF signaling, neuroinflammatory response and depressive-like behavior in mice
Guo, J., Lin, P., Zhao, X., Wang, Q., Wang, C.
Neuroscience. 2014; 263: 1-14
[Pubmed]  [Google Scholar]
2 Reduced numbers of cortical GABA-immunoreactive neurons in the chronic d-galactose treatment model of brain aging
Gu, X., Zhou, Y., Hu, X., Ke, K., Liu, C.
Neuroscience Letters. 2013; 549: 82-86
[Pubmed]  [Google Scholar]
3 Chlorbipram: A novel PDE4 inhibitor with improved safety as a potential antidepressant and cognitive enhancer
Zhang, M.-Z., Zhou, Z.-Z., Yuan, X., (...), Chen, Y.-P., Xu, J.-P.
European Journal of Pharmacology. 2013; 721(1): 56-63
[Pubmed]  [Google Scholar]
4 Anxiolytic-like effect of etazolate, a type 4 phosphodiesterase inhibitor in experimental models of anxiety
Jindal, A. and Mahesh, R. and Bhatt, S.
Indian Journal of Experimental Biology. 2013; 51(6): 444-449
[Pubmed]  [Google Scholar]

 

Read this article